Global impact of varicella vaccination programs

References

• Varicella vaccines. WHO position paper. Releve Epidemiol Hebd. 1998 Aug 7;73(32):241–248.
   Google Scholar
• Varicella and herpes zoster vaccines: WHO position paper, June 2014–recommendations. Vaccine. 2016 Jan 4;34(2):198–199. doi:10.1016/j.vaccine.2016.10.045.
   PubMed Web of Science ®Google Scholar
• Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. Contagiousness of Varicella in vaccinated cases: a household contact study. JAMA. 2004 Aug 11;292(6):704. doi:10.1001/jama.292.6.704.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T, Isomura S. Live vaccine used to prevent the spread of Varicella in children in hospital. The Lancet. 1974 Nov;304(7892):1288–1290. doi:10.1016/S0140-6736(74)90144-5.
   Google Scholar
• Ozaki T. Varicella vaccination in Japan: necessity of implementing a routine vaccination program. J Infect Chemother. 2013;19(2):188–195. doi:10.1007/s10156-013-0577-x.
   PubMed Web of Science ®Google Scholar
• Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global Varicella Vaccine Effectiveness: A Meta-analysis. Pediatrics. 2016 Mar 1;137(3):e20153741–e20153741. doi:10.1542/peds.2015-3741.
   PubMed Web of Science ®Google Scholar
• Hirose M, Gilio AE, Ferronato AE, Ragazzi SLB. The impact of varicella vaccination on varicella-related hospitalization rates: global data review. Rev Paul Pediatr Engl Ed. 2016 Sep;34(3):359–366. doi:10.1016/j.rpped.2015.12.006.
   PubMedGoogle Scholar
• Streng A, Grote V, Rack-Hoch A, Liese JG. Decline of neurologic Varicella complications in children during the first seven years after introduction of Universal varicella vaccination in Germany, 2005–2011. Pediatr Infect Dis J. 2017 Jan;36(1):79–86. doi:10.1097/INF.0000000000001356.
   PubMed Web of Science ®Google Scholar
• Spackova M, Muehlen M, Siedler A. Complications of Varicella after implementation of routine childhood varicella vaccination in Germany. Pediatr Infect Dis J. 2010 Sep;29(9):884–886. doi:10.1097/INF.0b013e3181e2817f.
   PubMed Web of Science ®Google Scholar
• Leung J, Broder KR, Marin M. Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review. Expert Rev Vaccines. 2017 Apr 3;16(4):391–400. doi:10.1080/14760584.2017.1294069.
   PubMed Web of Science ®Google Scholar
• Kuter BJ, Weibel RE, Guess HA, Matthews H, Morton DH, Neff BJ, Provost PJ, Watson BA, Starr SE, Plotkin SA. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine. 1991 Sep;9(9):643–647. doi:10.1016/0264-410X(91)90189-D.
   PubMed Web of Science ®Google Scholar
• Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J. 2004 Feb;23(2):132–137. doi:10.1097/01.inf.0000109287.97518.67.
   PubMed Web of Science ®Google Scholar
• Wutzler P, Bonanni P, Burgess M, Gershon A, Sáfadi MA, Casabona G. Varicella vaccination - the global experience. Expert Rev Vaccines. 2017 Aug 3;16(8):833–843. doi:10.1080/14760584.2017.1343669.
   PubMed Web of Science ®Google Scholar
• Chang L-Y, Huang L-M, Chang I-S, Tsai F-Y. Epidemiological characteristics of varicella from 2000 to 2008 and the impact of nationwide immunization in Taiwan. BMC Infect Dis [Internet]. 2011 Dec;11(1) [ Accessed 2018 Aug 8]. http://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-11-352.
   Google Scholar
• WHO vaccine-preventable diseases: monitoring system. [Internet]. World Health Organization 2018; 2018 [ Accessed 2018 Jul 30]. http://apps.who.int/immunization_monitoring/globalsummary/schedules.
   Google Scholar
• Varicella: Recommended vaccinations [Internet]. European Centre for Disease Prevention and Control (ECDC) 2018; 2018 [ Accessed 2018 Jul 30]. https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=11&SelectedCountryIdByDisease=−1.
   Google Scholar
• Marin M, Güris D, Chaves SS, Schmid S, Seward JF, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep. 2007 Jun 22;56(RR–4):1–40.
   PubMedGoogle Scholar
• Shah SS, Wood SM, Luan X, Ratner AJ. Decline in Varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against Varicella. Pediatr Infect Dis J. 2010 Mar;29(3):199–204. doi:10.1097/INF.0b013e3181bbf2a0.
   PubMed Web of Science ®Google Scholar
• Lopez AS, Zhang J, Brown C, Bialek S. Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era. Pediatrics. 2011 Feb 1;127(2):238–245. doi:10.1542/peds.2010-0962.
   PubMed Web of Science ®Google Scholar
• Leung J, Harpaz R. Impact of the maturing varicella vaccination program on Varicella and related outcomes in the United States: 1994–2012. J Pediatr Infect Dis Soc. 2016 Dec;5(4):395–402. doi:10.1093/jpids/piv044.
   PubMed Web of Science ®Google Scholar
• Lopez AS, Zhang J, Marin M. Epidemiology of Varicella during the 2-dose varicella vaccination program — United States, 2005–2014. MMWR Morb Mortal Wkly Rep. 2016 Sep 2;65(34):902–905. doi:10.15585/mmwr.mm6534a4.
   PubMed Web of Science ®Google Scholar
• Bialek SR, Perella D, Zhang J, Mascola L, Viner K, Jackson C, Lopez AS, Watson B, Civen R. Impact of a routine two-dose varicella vaccination program on Varicella epidemiology. Pediatrics. 2013 Nov 1;132(5):e1134–40. doi:10.1542/peds.2013-0863.
   PubMed Web of Science ®Google Scholar
• Leung J, Lopez AS, Blostein J, Thayer N, Zipprich J, Clayton A, Buttery V, Andersen J, Thomas CA, Del Rosario M, et al. Impact of the US two-dose varicella vaccination program on the epidemiology of varicella outbreaks: data from Nine States, 2005–2012. Pediatr Infect Dis J. 2015 Oct;34(10):1105–1109. doi:10.1097/INF.0000000000000821.
   PubMed Web of Science ®Google Scholar
• Quian J, Ruttimann R, Romero C, Dall’Orso P, Cerisola A, Breuer T, Greenberg M, Verstraeten T. Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005. Arch Dis Child. 2008 Oct 1;93(10):845–850. doi:10.1136/adc.2007.126243.
   PubMed Web of Science ®Google Scholar
• Avila-Aguero ML, Ulloa-Gutierrez R, Camacho-Badilla K, Soriano-Fallas A, Arroba-Tijerino R, Morice-Trejos A. Varicella prevention in Costa Rica: impact of a one-dose schedule universal vaccination. Expert Rev Vaccines. 2016 Mar 4;16(3):229–234. doi:10.1080/14760584.2017.1247700.
   PubMed Web of Science ®Google Scholar
• Andrade AL, Da da Silva Vieira MA, Minamisava R, Toscano CM, de Lima Souza MB, Fiaccadori F, Figueiredo CA, Curti SP, Nerger MLBR, Bierrenbach AL. Single-dose varicella vaccine effectiveness in Brazil: A case-control study. Vaccine. 2018 Jan;36(4):479–483. doi:10.1016/j.vaccine.2018.05.076.
   PubMed Web of Science ®Google Scholar
• Wormsbecker AE, Wang J, Rosella LC, Kwong JC, Seo CY, Crowcroft NS, Deeks SL, Borrow R. Twenty years of medically-attended pediatric varicella and herpes zoster in Ontario, Canada: a population-based study. Borrow R, editor. PLOS ONE. 2015 Jul 15;10(7):e0129483. doi:10.1371/journal.pone.0129483.
   PubMed Web of Science ®Google Scholar
• Baxter R, Tran TN, Ray P, Lewis E, Fireman B, Black S, Shinefield HR, Coplan PM, Saddier P. Impact of vaccination on the epidemiology of varicella: 1995-2009. Pediatrics. 2014 Jul 1;134(1):24–30. doi:10.1542/peds.2013-3604.
   PubMed Web of Science ®Google Scholar
• Kelly HA, Grant KA, Gidding H, Carville KS. Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2014 Oct 16;19(41).
   Google Scholar
• Chao DY, Chien YZ, Yeh YP, Hsu PS, Lian IB. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000–2008. Epidemiol Infect. 2012 Jun;140(06):1131–1140. doi:10.1017/S0950268811001786.
   PubMedGoogle Scholar
• Al-Tawfiq JA, AbuKhamsin A, Memish ZA. Epidemiology and impact of varicella vaccination: A longitudinal study 1994–2011. Travel Med Infect Dis. 2013 Sep;11(5):310–314. doi:10.1016/j.tmaid.2013.06.002.
   PubMed Web of Science ®Google Scholar
• Pozza F, Piovesan C, Russo F, Bella A, Pezzotti P, Emberti Gialloreti L. Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy. Vaccine. 2011 Nov;29(51):9480–9487. doi:10.1016/j.vaccine.2011.10.022.
   PubMed Web of Science ®Google Scholar
• Bechini A, Boccalini S, Baldo V, Cocchio S, Castiglia P, Gallo T, Giuffrida S, Locuratolo F, Tafuri S, Martinelli D, et al. Impact of universal vaccination against varicella in Italy: experiences from eight Italian Regions. Hum Vaccines Immunother. 2015 Jan;11(1):63–71. doi:10.4161/hv.34311.
   PubMed Web of Science ®Google Scholar
• Amodio E, Tramuto F, Cracchiolo M, Sciuto V, De Donno A, Guido M, Rota MC, Gabutti G, Vitale F. The impact of ten years of infant universal varicella vaccination in Sicily, Italy (2003–2012). Hum Vaccines Immunother. 2015 Jan;11(1):236–239. doi:10.4161/hv.36157.
   PubMed Web of Science ®Google Scholar
• Streng A, Grote V, Carr D, Hagemann C, Liese JG. Varicella routine vaccination and the effects on varicella epidemiology – results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011. BMC Infect Dis [Internet]. 2013 Dec;13(1) [ Accessed 2018 Aug 8]. http://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-13-303.
   Google Scholar
• Rieck T, Feig M, An der Heiden M, Siedler A, Wichmann O. Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015. Eurosurveillance [Internet]. 2017 Apr 27;22(17) [ Accessed 2017 Oct 29]. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=22784.
   Google Scholar
• Cenoz MG, Catalán JC, Zamarbide FI, Berastegui MA, Gurrea AB. [Impact of universal vaccination against chicken pox in Navarre, 2006-2010]. An Sist Sanit Navar. 2011 Aug;34(2):193–202.
   PubMed Web of Science ®Google Scholar
• García Cenoz M, Castilla J, Chamorro J, Martínez-Baz I, Martínez-Artola V, Irisarri F, Arriazu M, Ezpeleta C, Barricarte A.Impact of universal two-dose vaccination on varicella epidemiology in Navarre, Spain, 2006 to 2012. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2013 Aug 8;18(32):20552.
   PubMedGoogle Scholar
• Cenoz MG, Martínez-Artola V, Guevara M, Ezpeleta C, Barricarte A, Castilla J. Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain. Hum Vaccines Immunother. 2013 May 14;9(5):1172–1176. doi:10.4161/hv.23451.
   PubMed Web of Science ®Google Scholar
• Latasa P, Gil de Miguel A, Barranco Ordoñez MD, Rodero Garduño I, Sanz Moreno JC, Ordobás Gavín M, Esteban Vasallo M, Garrido-Estepa M, García-Comas L. Effectiveness and impact of a single-dose vaccine against chickenpox in the community of Madrid between 2001 and 2015. Hum Vaccines Immunother. 2018 May 17:1–7. doi:10.1080/21645515.2018.1475813.
   Web of Science ®Google Scholar
• García Comas L, Latasa Zamalloa P, Alemán Vega G, Ordobás Gavín M, Arce Arnáez A, Rodero Garduño I, Estirado Gómez A, Marisquerena EI. Descenso de la incidencia de la varicela en la Comunidad de Madrid tras la vacunación infantil universal. Años 2001-2015. Aten Primaria. 2018 Jan;50(1):53–59. doi:10.1016/j.aprim.2017.01.010.
   PubMedGoogle Scholar
• Henry O, Brzostek J, Czajka H, Leviniene G, Reshetko O, Gasparini R, Pazdiora P, Plesca D, Desole MG, Kevalas R et al. One or two doses of live varicella virus-containing vaccines: efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life. Vaccine. 2018 Jan;36(3):381–387. doi:10.1016/j.vaccine.2018.05.076.
   PubMed Web of Science ®Google Scholar
• Scotta MC, Paternina-de la Ossa R, Lumertz MS, Jones MH, Mattiello R, Pinto LA. Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil. Vaccine. 2018 Jan;36(2):280–284. doi:10.1016/j.vaccine.2018.05.076.
   PubMed Web of Science ®Google Scholar
• Carville KS, Riddell MA, Kelly HA. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia. Vaccine. 2010 Mar;28(13):2532–2538. doi:10.1016/j.vaccine.2010.01.036.
   PubMed Web of Science ®Google Scholar
• Heywood AE, Wang H, Macartney KK, McIntyre P. Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study. Bull World Health Organ. 2014 Aug 1;92(8):593–604. doi:10.2471/BLT.13.126128.
   PubMed Web of Science ®Google Scholar
• Elbaz M, Paret G, Yohai AB, Halutz O, Grisaru-Soen G. Immunisation led to a major reduction in paediatric patients hospitalised because of the varicella infection in Israel. Acta Paediatr. 2016 Apr;105(4):e161–6. doi:10.1111/apa.13407.
   PubMed Web of Science ®Google Scholar
• Waye A, Jacobs P, Tan B. The impact of the universal infant varicella immunization strategy on Canadian varicella-related hospitalization rates. Vaccine. 2013 Oct;31(42):4744–4748. doi:10.1016/j.vaccine.2013.08.022.
   PubMed Web of Science ®Google Scholar
• Tan B, Bettinger J, McConnell A, Scheifele D, Halperin S, Vaudry W, Law B. The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000–2008. Pediatr Infect Dis J. 2012 Sep;31(9):956–963. doi:10.1097/INF.0b013e318260cc4d.
   PubMed Web of Science ®Google Scholar
• Russell ML, Dover DC, Simmonds KA, Svenson LW. Shingles in Alberta: before and after publicly funded varicella vaccination. Vaccine. 2014 Oct;32(47):6319–6324. doi:10.1016/j.vaccine.2013.09.018.
   PubMed Web of Science ®Google Scholar
• Ávila-Agüero ML, Beltrán S, Castillo JB, Castillo Díaz ME, Chaparro LE, Deseda C, Debbag R, Espinal C, Falleiros-Arlant LH, González Mata AJ, et al. Varicella epidemiology in Latin America and the Caribbean. Expert Rev Vaccines [Internet]. 2017 Dec 19 [ Accessed 2018 Mar 1]. https://www.tandfonline.com/doi/full/10.1080/14760584.2018.1418327.
   Web of Science ®Google Scholar
• de Martino Mota A, Carvalho-Costa FA. Varicella zoster virus related deaths and hospitalizations before the introduction of universal vaccination with the tetraviral vaccine. J Pediatr (Rio J). 2016 Jul;92(4):361–366. doi:10.1016/j.jped.2015.10.003.
   PubMed Web of Science ®Google Scholar
• Riera-Montes M, Bollaerts K, Heininger U, Hens N, Gabutti G, Gil A, Nozad B, Mirinaviciute G, Flem E, Souverain A et al. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. BMC Infect Dis [Internet]. 2017 Dec;17(1) [ Accessed 2018 Mar 1]. http://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-017-2445-2.
   PubMedGoogle Scholar
• European Centre for Disease Prevention and Control. Varicella vaccination in the European Union. Stockholm: ECDC; 2015. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/Varicella-Guidance-2015.pdf.
   Google Scholar
• Helmuth IG, Poulsen A, Suppli CH, Mølbak K. Varicella in Europe—A review of the epidemiology and experience with vaccination. Vaccine. 2015 May;33(21):2406–2413. doi:10.1016/j.vaccine.2015.03.055.
   PubMed Web of Science ®Google Scholar
• Siedler A, Arndt U. Surveillance and outbreak reports. Impact of the routine varicella vaccination programme on varicella epidemiology in Germany [Internet]; 2010 Apr 1. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19530T.
   Google Scholar
• Liese JG, Cohen C, Rack A, Pirzer K, Eber S, Blum M, Greenberg M, Streng A. The effectiveness of varicella vaccination in children in Germany: a case-control study. Pediatr Infect Dis J. 2013 Sep;32(9):998–1004. doi:10.1097/INF.0b013e31829ae263.
   PubMed Web of Science ®Google Scholar
• Siedler A, Rieck T, Tolksdorf K. Strong additional effect of a second Varicella vaccine dose in children in Germany, 2009-2014. J Pediatr. 2016 Jun;173:202–206.e2. doi:10.1016/j.jpeds.2016.02.040.
   PubMed Web of Science ®Google Scholar
• Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Hum Vaccines Immunother. 2014 Dec 2;10(12):3594–3600. doi:10.4161/hv.34426.
   PubMed Web of Science ®Google Scholar
• Bella A, Trucchi C, Gabutti G, Cristina Rota M. Burden of varicella in Italy, 2001–2010: analysis of data from multiple sources and assessment of universal vaccination impact in three pilot regions. J Med Microbiol. 2015 Nov 1;64(11):1387–1394. doi:10.1099/jmm.0.000061.
   PubMedGoogle Scholar
• Boccalini S, Bonanni P, Bechini A. Preparing to introduce the varicella vaccine into the Italian immunisation programme: varicella-related hospitalisations in Tuscany, 2004–2012. Eurosurveillance [Internet]. 2016 Jun 16;21(24) [ Accessed 2018 Aug 8]. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=22507.
   Google Scholar
• Gil-Prieto R, Walter S, Gonzalez-Escalada A, Garcia-Garcia L, Marín-García P, Gil-de-Miguel A. Different vaccination strategies in Spain and its impact on severe varicella and zoster. Vaccine. 2014 Jan;32(2):277–283. doi:10.1016/j.vaccine.2013.11.008.
   PubMed Web of Science ®Google Scholar
• Gil-Prieto R, Garcia-Garcia L, San-Martin M, Gil-de-Miguel A. Varicella vaccination coverage inverse correlation with varicella hospitalizations in Spain. Vaccine. 2014 Dec;32(52):7043–7046. doi:10.1016/j.vaccine.2014.10.076.
   PubMed Web of Science ®Google Scholar
• Critselis E, Theodoridou K, Alexopoulou Z, Theodoridou M, Papaevangelou V. Time trends in pediatric Herpes zoster hospitalization rate after Varicella immunization: herpes zoster hospitalization time trends. Pediatr Int. 2016 Jun;58(6):534–536. doi:10.1111/ped.12790.
   PubMed Web of Science ®Google Scholar
• Dbaibo G, Tatochenko V, Wutzler P. Issues in pediatric vaccine-preventable diseases in low- to middle-income countries. Hum Vaccines Immunother. 2016 Sep;12(9):2365–2377. doi:10.1080/21645515.2016.1181243.
   PubMed Web of Science ®Google Scholar
• Hussey H, Abdullahi L, Collins J, Muloiwa R, Hussey G, Kagina B. Varicella zoster virus-associated morbidity and mortality in Africa – a systematic review. BMC Infect Dis [Internet]. 2017 Dec;17(1) [ Accessed 2018 Aug 8]. https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-017-2815-9.
   PubMedGoogle Scholar
• Sheridan SL, Quinn HE, Hull BP, Ware RS, Grimwood K, Lambert SB. Impact and effectiveness of childhood varicella vaccine program in Queensland, Australia. Vaccine. 2017 Jun;35(27):3490–3497. doi:10.1016/j.vaccine.2017.05.013.
   PubMed Web of Science ®Google Scholar
• Khandaker G, Marshall H, Peadon E, Zurynski Y, Burgner D, Buttery J, Gold M, Nissen M, Elliott EJ, Burgess M, et al. Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia. Arch Dis Child. 2011 May 1;96(5):453–456. doi:10.1136/adc.2010.206037.
   PubMed Web of Science ®Google Scholar
• Chen L-K, Arai H, Chen LY, Chou MY, Djauzi S, Dong B, Kojima T, Kwon KT, Leong HN, Leung EM et al. Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific. BMC Infect Dis [Internet]. 2017 Dec;17(1) [ Accessed 2018 Aug 8]. http://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-017-2198-y.
   Google Scholar
• Yoshikawa T, Kawamura Y, Ohashi M. Universal varicella vaccine immunization in Japan. Vaccine. 2016 Apr;34(16):1965–1970. doi:10.1016/j.vaccine.2016.10.045.
   PubMed Web of Science ®Google Scholar
• Hattori F, Miura H, Sugata K, Yoshikawa A, Ihira M, Yahata Y, Kamiya H, Tanaka-Taya K, Yoshikawa T. Evaluating the effectiveness of the universal immunization program against varicella in Japanese children. Vaccine. 2017 Sep;35(37):4936–4941. doi:10.1016/j.vaccine.2017.07.090.
   PubMed Web of Science ®Google Scholar
• Lee YH, Choe YJ, Cho S, Kang CR, Bang JH, Oh M, Lee J-K. Effectiveness of varicella vaccination program in preventing laboratory-confirmed cases in children in Seoul, Korea. J Korean Med Sci. 2016;31(12):1897. doi:10.3346/jkms.2016.31.12.1897.
   PubMed Web of Science ®Google Scholar
• Oh SH, Choi EH, Shin SH, Kim Y-K, Chang JK, Choi KM, Hur JK, Kim K-H, Kim JY, Chung EH, et al. Varicella and varicella vaccination in South Korea. Plotkin SA, editor. Clin Vaccine Immunol. 2014 May;21(5):762–768. doi:10.1128/CVI.00645-13.
   PubMed Web of Science ®Google Scholar
• Choi UY, Huh DH, Kim JH, Kang JH. Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group. Hum Vaccines Immunother. 2016 Oct 2;12(10):2560–2564. doi:10.1080/21645515.2016.1190056.
   PubMed Web of Science ®Google Scholar
• Huang W-C, Huang L-M, Chang I-S, Tsai F-Y, Chang L-Y. Varicella breakthrough infection and vaccine effectiveness in Taiwan. Vaccine. 2011 Mar;29(15):2756–2760. doi:10.1016/j.vaccine.2011.01.092.
   PubMed Web of Science ®Google Scholar
• Al-Turab M, Chehadeh W. Varicella infection in the Middle East: prevalence, complications, and vaccination. J Res Med Sci. 2018;23(1):19. doi:10.4103/jrms.JRMS_979_17.
   PubMedGoogle Scholar
• van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine. 2011 Mar 16;29(13):2411–2420. doi:10.1016/j.vaccine.2011.01.037.
   PubMed Web of Science ®Google Scholar
• Taylor JA. Herd immunity and the varicella vaccine: is it a good thing? Arch Pediatr Adolesc Med. 2001 Apr;155(4):440–441. doi:10.1001/archpedi.155.4.440.
   PubMedGoogle Scholar
• Chaves SS, Lopez AS, Watson TL, Civen R, Watson B, Mascola L, Seward JF. Varicella in infants after implementation of the US varicella vaccination program. Pediatrics. 2011 Dec 1;128(6):1071–1077. doi:10.1542/peds.2010-3664.
   PubMed Web of Science ®Google Scholar
• Kappagoda C, Shaw P, Burgess M, Botham S, Cramer L. Varicella vaccine in non-immune household contacts of children with cancer or leukaemia: varicella vaccine in contacts of children with cancer. J Paediatr Child Health. 1999 Aug;35(4):341–345. doi:10.1046/j.1440-1754.1999.00382.x.
   Web of Science ®Google Scholar
• Tseng HF, Smith N, Marcy SM, Sy LS, Jacobsen SJ. Incidence of herpes zoster among children vaccinated with Varicella Vaccine in a prepaid health care plan in the United States, 2002–2008. Pediatr Infect Dis J. 2009 Dec;28(12):1069–1072. doi:10.1097/INF.0b013e3181acf84f.
   PubMed Web of Science ®Google Scholar
• Weinmann S, Chun C, Schmid DS, Roberts M, Vandermeer M, Riedlinger K, Bialek SR, Marin M. Incidence and clinical characteristics of herpes zoster among children in the Varicella Vaccine Era, 2005–2009. J Infect Dis. 2013 Dec 1;208(11):1859–1868. doi:10.1093/infdis/jit405.
   PubMed Web of Science ®Google Scholar
• Civen R, Marin M, Zhang J, Abraham A, Harpaz R, Mascola L, Bialek SR. Update on incidence of herpes zoster among children and adolescents after implementation of varicella vaccination, Antelope Valley, CA, 2000 to 2010. Pediatr Infect Dis J. 2016 Oct;35(10):1132–1136. doi:10.1097/INF.0000000000001249.
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000 Dec;125(3):651–669. doi:10.1017/S0950268800004714.
   PubMed Web of Science ®Google Scholar
• Patel MS, Gebremariam A, Davis MM. Herpes zoster–related hospitalizations and expenditures before and after introduction of the Varicella Vaccine in the United States. Infect Control Hosp Epidemiol. 2008 Dec;29(12):1157–1163. doi:10.1086/590662.
   PubMed Web of Science ®Google Scholar
• Kawai K, Yawn BP, Wollan P, Harpaz R. Increasing incidence of herpes zoster over a 60-year period from a population-based study. Clin Infect Dis. 2016 Jul 15;63(2):221–226. doi:10.1093/cid/ciw296.
   PubMed Web of Science ®Google Scholar
• Leung J, Harpaz R, Molinari N-A, Jumaan A, Zhou F. Herpes zoster incidence among insured persons in the United States, 1993–2006: evaluation of impact of varicella vaccination. Clin Infect Dis. 2011 Feb 1;52(3):332–340. doi:10.1093/cid/ciq077.
   PubMed Web of Science ®Google Scholar
• Nelson MR, Britt HC, Harrison CM. Evidence of increasing frequency of herpes zoster management in Australian general practice since the introduction of a varicella vaccine. Med J Aust. 2010 Jul 19;193(2):110–113.
   PubMed Web of Science ®Google Scholar
• Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Hengel H, Greiner W, et al. Current and future effects of varicella and herpes zoster vaccination in Germany – insights from a mathematical model in a country with universal varicella vaccination. Hum Vaccines Immunother. 2016 Feb 2:1–11. doi:10.1080/21645515.2015.1135279.
   Web of Science ®Google Scholar
• Unim B, Saulle R, Boccalini S, Taddei C, Ceccherini V, Boccia A, Bonanni P, La Torre G. Economic evaluation of varicella vaccination: results of a systematic review. Hum Vaccines Immunother. 2013 Sep 19;9(9):1932–1942. doi:10.4161/hv.25228.
   PubMed Web of Science ®Google Scholar
• Gao Z, Gidding HF, Wood JG, MacINTYRE CR. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia. Epidemiol Infect. 2010 Apr;138(04):457. doi:10.1017/S0950268809990860.
   PubMedGoogle Scholar
• Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O. Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health [Internet]. 2015 Dec;15(1) [ Accessed 2018 Aug 8]. http://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-015-1861-8.
   PubMedGoogle Scholar